[FULC] QoQ Quarter Result on 31-Mar-2023 [#Q4]

Stock
[FULC] Fulcrum Therapeutics, Inc.
Announcement Date
15-May-2023
Financial Year
2022
Quarter
31-Mar-2023 [#Q4]
Profit Trend
QoQ- 8.51%
YoY- 16.40%
Quarter Report
FULC's Result
FULC's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 871 759 880 295 685 1,183 1,882 -40.08%
PBT -24,756 -24,017 -23,783 -24,779 -26,135 -23,738 -34,070 -19.12%
Tax 3,161 409 525 -3,161 -2,505 313 -24 -
NP -24,756 -24,017 -23,783 -21,618 -23,630 -24,051 -34,070 -19.12%
Tax Rate - - - - - - - -
Total Cost 25,627 24,776 24,663 21,913 24,315 25,234 35,952 -20.15%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -2,842.25 -3,164.30 -2,702.61 -7,328.14 -3,449.64 -2,033.05 -1,810.31 34.97%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.40 -0.39 -0.38 -0.36 -0.45 -0.52 -0.83 -38.44%
EPS Diluted -0.40 -0.39 -0.38 -0.36 -0.45 -0.52 -0.83 -38.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.